These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8068432)

  • 1. [Clinical aspects on juvenile parkinsonism].
    Ishikawa A
    No To Shinkei; 1994 Jun; 46(6):517-22. PubMed ID: 8068432
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopa responsive dystonia and juvenile Parkinson's disease: two subtypes of the same disorder?
    Lamberti P; de Mari M; Iliceto G; Federico F
    Acta Neurol (Napoli); 1992; 14(4-6):451-4. PubMed ID: 1293988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dystonia preceding dopa-responsive parkinsonism--heterogeneous clinical features].
    Miwa H; Mizuno Y
    No To Shinkei; 1996 Feb; 48(2):149-54. PubMed ID: 8865694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia.
    Furukawa Y; Mizuno Y; Narabayashi H
    Adv Neurol; 1996; 69():327-37. PubMed ID: 8615147
    [No Abstract]   [Full Text] [Related]  

  • 5. Hereditary progressive dystonia with marked diurnal fluctuation: clinicopathophysiological identification in reference to juvenile Parkinson's disease.
    Segawa M; Nomura Y; Kase M
    Adv Neurol; 1987; 45():227-34. PubMed ID: 3825694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Autosomal recessive early-onset parkinsonism with diurnal fluctuation (AR-EPDF)--clinical characteristics].
    Yamamura Y; Kohriyama T; Kawakami H; Kaseda Y; Kuzuhara S; Nakamura S
    Rinsho Shinkeigaku; 1996 Aug; 36(8):944-50. PubMed ID: 8958746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis.
    Nygaard TG
    Adv Neurol; 1993; 60():577-85. PubMed ID: 8420194
    [No Abstract]   [Full Text] [Related]  

  • 8. Parkinsonism following dystonia in three patients.
    Katchen M; Duvoisin RC
    Mov Disord; 1986; 1(2):151-7. PubMed ID: 3504239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF biopterin levels and clinical features of patients with juvenile parkinsonism.
    Furukawa Y; Nishi K; Kondo T; Mizuno Y; Narabayashi H
    Adv Neurol; 1993; 60():562-7. PubMed ID: 8420192
    [No Abstract]   [Full Text] [Related]  

  • 10. [Early morning dystonia: a complication of levodopa therapy in Parkinson disease. Presentation of 4 cases].
    Molina Arjona JA; Arnal García C; Calandre Hoenigsfeld L; Bermejo Pareja F
    Med Clin (Barc); 1984 Jun; 83(2):47-9. PubMed ID: 6471944
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hereditary aspects of Parkinson's disease (review of the literature)].
    Atadzhanov M
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(6):919-26. PubMed ID: 4584983
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic linkage studies in autosomal dominantly inherited L-DOPA responsive parkinsonism. Evaluation of candidate genes.
    Gasser T; Wszolek Z; Supala A; Trofatter J; Ozelius L; Uitti RJ; Pfeiffer RF; Gusella J; Calne D; Breakefield XO
    Adv Neurol; 1996; 69():87-95. PubMed ID: 8615189
    [No Abstract]   [Full Text] [Related]  

  • 13. Nosological concept of juvenile parkinsonism with reference to the dopa-responsive syndrome.
    Yokochi M
    Adv Neurol; 1993; 60():548-52. PubMed ID: 8420189
    [No Abstract]   [Full Text] [Related]  

  • 14. [Juvenile parkinsonism: its neuropathological aspects].
    Takahashi H
    No To Shinkei; 1994 Jun; 46(6):523-9. PubMed ID: 8068433
    [No Abstract]   [Full Text] [Related]  

  • 15. Autosomal recessive juvenile Parkinson's disease with partial trisomy of chromosome 6q syndrome: a case report.
    Namihira T; Hattori N; Shiroma S; Miyazato Y
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):672-3. PubMed ID: 15601396
    [No Abstract]   [Full Text] [Related]  

  • 16. Hereditary progressive dystonia with marked diurnal fluctuation. Pathophysiological importance of the age of onset.
    Segawa M; Nomura Y
    Adv Neurol; 1993; 60():568-76. PubMed ID: 8420193
    [No Abstract]   [Full Text] [Related]  

  • 17. Arg(184)His mutant GTP cyclohydrolase I, causing recessive hyperphenylalaninemia, is responsible for dopa-responsive dystonia with parkinsonism: a case report.
    Kikuchi A; Takeda A; Fujihara K; Kimpara T; Shiga Y; Tanji H; Nagai M; Ichinose H; Urano F; Okamura N; Arai H; Itoyama Y
    Mov Disord; 2004 May; 19(5):590-3. PubMed ID: 15133828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile parkinsonism--some clinical, pharmacological, and neuropathological aspects.
    Yokochi M; Narabayashi H; Iizuka R; Nagatsu T
    Adv Neurol; 1984; 40():407-13. PubMed ID: 6141711
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopa-responsive, nonprogressive juvenile parkinsonism: report of a case.
    Rajput A; Kishore A; Snow B; Bolton CF; Rajput AH
    Mov Disord; 1997 May; 12(3):453-6. PubMed ID: 9159748
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacology of foot dystonia in parkinsonism.
    Poewe WH; Lees AJ
    Clin Neuropharmacol; 1987; 10(1):47-56. PubMed ID: 3545460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.